Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage

Thrombosis Research

Volumn 136, Issue 5, 2015, Pages 1040-1044

  Witt, Daniel M ^a   Clark, Nathan P ^b   Martinez, Kerri ^b   Schroeder, Allison ^c   Garcia, David ^d   Crowther, Mark A ^e   Ageno, Walter ^f   Dentali, Francesco ^f   Ye, Xiangyang ^a   Hylek, Elaine ^g   Delate, Thomas ^b  

^a UNIVERSITY OF UTAH   (United States)

^b Pharmacy Department   (United States)

^c Veterans Administration   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Death; Hemorrhage; Intracranial hemorrhages; Thromboembolism; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; EXTRACRANIAL BLEEDING; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYSTEMIC EMBOLISM; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; AGED; CHEMICALLY INDUCED; RISK;

AGED; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; MALE; RISK; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84948701464     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.10.002     Document Type: Article

References (18)

1. D.M. Witt, T. Delate, E.M. Hylek, and et al. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes Thromb. Res. 132 2013 770 775
2. B.F. Gage, E. Birman-Deych, R. Kerzner, M.J. Radford, D.S. Nilasena, and M.W. Rich Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall Am. J. Med. 118 2005 612 617
3. T. Steiner, R. Al-Shahi Salman, R. Beer, and et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage Int. J. Stroke 9 2014 840 855
4. L.B. Morgenstern, J.C. Hemphill 3rd, C. Anderson, and et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 41 2010 2108 2129
5. D. Poli, E. Antonucci, F. Dentali, and et al. Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study Neurology 82 2014 1020 1026
6. European Stroke Initiative Writing C, Writing Committee for the EEC, T. Steiner, and et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee Cerebrovasc. Dis. 22 2006 294 316
7. D.M. Witt, M.A. Sadler, R.L. Shanahan, G. Mazzoli, and D.J. Tillman Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy Chest 127 2005 1515 1522
8. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb. Haemost. 69 1993 236 239
9. D.O. Clark, M. Von Korff, K. Saunders, W.M. Baluch, and G.E. Simon A chronic disease score with empirically derived weights Med. Care 33 1995 783 795
10. M. Von Korff, E.H. Wagner, and K. Saunders A chronic disease score from automated pharmacy data J. Clin. Epidemiol. 45 1992 197 203
11. D.M. Witt, T. Delate, D.A. Garcia, and et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding Arch. Intern. Med. 172 2012 1484 1491
12. W. Qureshi, C. Mittal, I. Patsias, and et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation Am. J. Cardiol. 113 2014 662 668
13. J.A. Nieto, T. Camara, E. Gonzalez-Higueras, and et al. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry Thromb. Haemost. 100 2008 789 796
14. F. Khalid, W. Qureshi, S. Qureshi, Z. Alirhayim, K. Garikapati, and I. Patsias Impact of restarting warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage Ren. Fail. 35 2013 1228 1235
15. C. Chai-Adisaksopha, C. Hillis, M. Monreal, D.M. Witt, and M. Crowther Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis Thromb. Haemost. 2015 114 [Epub ahead of print]
16. J.B. Kuramatsu, S.T. Gerner, P.D. Schellinger, and et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage J. Am. Med. Assoc. 313 2015 824 1386
17. D. Yung, M.K. Kapral, E. Asllani, J. Fang, and D.S. Lee Investigators of the Registry of the Canadian Stroke N. Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study Can. J. Cardiol. 28 2012 33 39
18. A. Majeed, Y.K. Kim, R.S. Roberts, M. Holmstrom, and S. Schulman Optimal timing of resumption of warfarin after intracranial hemorrhage Stroke 41 2010 2860 2866